Searched for
CVS CAREMARK
Eli Lilly drops CVS drug plan for staff after Novo obesity deal: ReportEli Lilly is switching its employee drug benefit plan from CVS Health to Rightway, a move reportedly linked to CVS's decision to stop cover...- Pharma middlemen propose regulatory changes to avoid Trump administration rules: ReportPharmacy benefit managers, facing increased scrutiny from the Trump administration, are reportedly developing proposals to modify their pra...
- CVS Health Stock surges over 5% after stellar Q2 and huge profit upgrade for 2025CVS Health stock surged over 5% following robust second-quarter results, surpassing analyst expectations with an EPS of $1.81 and revenue o...
- Zydus Lifesciences Q3 Results: Net profit jumps 30% to Rs 1023 croreZydus Lifesciences Q3 Earnings: Zydus Lifesciences reported a 30% YoY rise in Q3FY25 net profit to ₹1,023.5 crore, driven by strong US grow...
- UnitedHealth, the company that employed slain CEO Brian Thompson, allegedly overcharged some cancer patients by more than 1,000% for their medicationsUnitedHealth, in which slain CEO Brian Thompson was employed, has been allegedly accused of overcharging patients suffering from dangerous ...
- Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formularyZydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to ...
- Insurer stocks fall after Trump says 'we're going to knock out the middleman'Trump targeted pharmacy benefit managers for increasing drug prices. He pledged to remove them from the system. This caused share drops for...
- Zydus Lifesciences appoints Punit Patel as President & CEO, AmericasBefore joining Zydus, he was the President of Red Oak Sourcing, leading the company's "multibillion-dollar generic portfolio", overseeing a...
- Facebook is now Meta: A look at other corporate rebranding effortsFacebook Inc. is changing its name to Meta Platforms Inc., joining a long list of companies — including Google, Philip Morris and Nefflix —...
- India's pharma industry may touch $55 billion by 2020: Assocham and TechSci reportConsolidation of pharmacy players in North America has resulted in the presence of leading firms that hold better bargaining power, it adde...
- Ex-Ranbaxy top executive Rajiv Gulati rolls out drug delivery startupRajiv Gulati, who quit last year as president Ranbaxy, is floating a start-up which offers a 'mail order service' for chronic medicines.
- India may miss pharma export target; regulatory factors to halve growth to 5%India’s drug makers export more than $4 billion (Rs 24,970 crore) of products to the US out of their annual exports of around $15 billion.
- Pharma consolidation in US hurts mid-sized Indian drug makersSeveral mid-sized Indian drug makers heavily dependent on the United States are beginning to suffer because consolidation in the US pharmac...
- Patni appoints Rajiv Ranjan as EVP & Global Hd of Business OpsIT major, Patni Computer Systems on Tuesday announced the appointment of Rajiv Ranjan as Executive Vice-President and Global Head of Busine...
- Healthcare bill upsets US insurers, pharma cosUS drugmakers, medical device companies and insurers are gearing up for another chance to make changes to House-passed legislation overhaul...
- Walgreen offers $2.8 bn to buy Longs Drug StoresWalgreen Co. made an offer to buy Longs Drug Stores Corp. for $2.8 billion.
- Walgreens offers $2.8B to buy Longs Drug StoresWalgreen Co made an offer late Friday to buy Longs Drug Stores Corp. for $2.8 billion, hoping to unseat a rival offer from CVS Caremark Cor...
- Hunt for discount stores beginsThat $3.20 latte at Starbucks or the $300 handbag at Coach may no longer be affordable luxuries.
- Johnson & Johnson, Wyeth pull infant cold medicationsDrug makers voluntarily pulled kids' cold medicines off the market less than two weeks after the US government warned of potential health r...
- US drugstore chain CVS buys Caremark for $21bnDrugstore chain CVS said it was buying pharmacy manager Caremark Rx for $21bn, the latest foray by a group that analysts say aims for a lar...
Load More
